Center for Genetic Engineering and Biotechnology (CIGB)

Genetic Engineering and Biotechnology for biomedical, agricultural and industrial applications
Ave. 31 No. 15802 e/ 158 y 190, Cubanacán, Playa, P.O. Box 6162
Ave. 31 e/ 158 y 190
Postal code
(+53)72504101 / (+53)72716022
Contact person's name
Dra. Marta Ayala Avila (General Director), Dra Miladys Limonta Fernández (Business Development Director)
Short description of the company
The Center for Genetic Engineering and Biotechnology (CIGB) is a distinctive Cuban biotechnology company, which investigates, develops, produces and markets novel biotechnological applications and preventive, therapeutic and diagnostic biopharmaceutical products, for the biomedical, agricultural and industrial sectors, for one health.
Company`s description
The CIGB is top-tier productive scientific complex that develops vaccines, drugs and diagnostics for human, animals and plants. We investigate, develop, produce and commercialize novel biotechnological and pharmaceutical products, with a positive impact on human, animal and plant health, and on industrial productions, in harmony with the environment. Contribute to the socioeconomic development of Cuba. Our aim is to maintain leadership as one of the companies with relevant scientific and technical contribution to health, and to achieve a solid international position with biotechnological innovation, in harmony with the environment, for sustainable socioeconomic development. More information is avalilable at and
Partner search
Pharma and Biotech Companies, Investors, Technological entities, Universities
Biomedical and Agricultural research Projects
Short content description
The CIGB activity spans from scientific research and discovery, scaling-up, production, and commercialization, both locally and abroad. For more than 35 years the Center has maintained a wide portfolio of projects and products addressing relevant targets of human and animal health, agriculture and industry. In order to profit from partners strengths and to build synergic alliances, the CIGB looks for counterparts interested in the joint development of human and animal health, agriculture and industrial projects, based on a diversity of business models.
The programme is co-financed by the Slovenian Enterprise Fund and the European Union, namely from the European Fund for Regional Development. It is carried out on the basis of the Substantial Support of Fund Recipients (SME) programme from 2018 to 2023 within the framework of the Operational Programme for the Implementation of European Cohesion Policy from 2014 to 2020.